NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19 | NIH: National Institute of Allergy and Infectious Diseases

NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19 | NIH: National Institute of Allergy and Infectious Diseases

NIH Begins Clinical Trial of Hydroxychloroquine and Azithromycin to Treat COVID-19

Study Enrolling Adults with Mild to Moderate COVID-19 in the United States

May 14, 2020